It has been reported that red blood cell width (RDW) is a marker associated with the presence and adverse outcomes of various diseases. However, no data are available on the correlation of RDW with presence, stage, and grade in patients with renal cell carcinoma (RCC) yet. By retrospectively analyzing clinical and laboratory data at baseline of histologically confirmed RCC cases and controls, the present study demonstrated that the RDW values were significantly higher in patients with RCC than those in controls, and the baseline RDW value was independently associated with the presence of RCC. Besides, the data revealed a positive association between RCC stage and grade and the level of RDW. These findings may have important clinical implications due to future application using a RDW value in predicting RCC.
Bibliographical noteFunding Information:
This paper was supported by the National Natural Science Foundation of China (Grant 30950018) and the Beijing Natural Science Foundation (Grant 7113174).
© 2014 Fang-Ming Wang et al.
Copyright 2017 Elsevier B.V., All rights reserved.